Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Tissue Diagnostics Market Forecasts to 2022 - Rising Number of Clinical Trials for Cancer Drugs - Research and Markets

Research and Markets
Posted on: 08 Dec 17

The "Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User - Global Forecast to 2022" report has been added to Research and Markets' offering.

Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period.

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics. On the other hand, complex regulatory frameworks that delay the approval of new diagnostic products and lack of infrastructure are expected to challenge market growth to a certain extent.

Drivers

  • Rising Incidence of Cancer
  • Growing Healthcare Expenditure
  • Improving Infrastructure for Cancer Diagnosis
  • Technological Advancements in Tissue Diagnostics

Restraints

  • High Degree of Consolidation

Opportunities

  • Emerging Markets
  • Growing Demand for Personalized Medicine
  • Rising Number of Clinical Trials for Cancer Drugs

Challenges

  • Stringent Regulatory Requirements
  • Lack of Infrastructure And Low Awareness in Middle- And Low- Income Countries

Trends

  • Increasing Number of Reagent Rental Agreements

The global tissue diagnostics market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Tissue Diagnostics Market, By Product

7 Tissue Diagnostics Market, By Technology

8 Tissue Diagnostics Market, By Disease

9 Tissue Diagnostics Market, By End User

10 Tissue Diagnostics Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott
  • Abcam
  • Agilent Technologies
  • BD
  • Bio Sb
  • Biogenex
  • Cell Signaling Technology
  • Danaher
  • Merck
  • Qiagen
  • Roche
  • Sakura Finetek Japan
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/gr23b7/tissue

View source version on businesswire.com: http://www.businesswire.com/news/home/20171208005253/en/

Business Wire
www.businesswire.com

Last updated on: 08/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.